Colchicine: Targeted Relief for Gout and Inflammation
| Product dosage: 0.5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $57.23 (0%) | 🛒 Add to cart |
| 90 | $0.79 | $85.84 $71.29 (17%) | 🛒 Add to cart |
| 120 | $0.70 | $114.46 $84.34 (26%) | 🛒 Add to cart |
| 180 | $0.62 | $171.69 $112.45 (35%) | 🛒 Add to cart |
| 270 | $0.57 | $257.53 $152.61 (41%) | 🛒 Add to cart |
| 360 | $0.54
Best per pill | $343.37 $193.77 (44%) | 🛒 Add to cart |
Synonyms | |||
Colchicine is a time-tested, potent medication primarily indicated for the treatment and prophylaxis of acute gout flares. It belongs to the class of anti-gout agents and works by inhibiting microtubule polymerization, thereby reducing the migration of neutrophils to inflamed areas and diminishing the inflammatory response. This mechanism provides a targeted approach to managing the intense pain and swelling characteristic of gout attacks. Its use is also established in the management of familial Mediterranean fever (FMF) and other inflammatory conditions, under strict medical supervision.
Features
- Active Ingredient: Colchicine
- Available Forms: Oral tablets (typically 0.6 mg)
- Mechanism of Action: Binds to tubulin, inhibiting microtubule assembly and neutrophil motility
- Prescription Status: Prescription-only medication
- Half-life: Approximately 27–31 hours
- Metabolism: Primarily hepatic via CYP3A4
Benefits
- Rapid reduction in the pain and inflammation associated with acute gout attacks
- Effective prophylaxis for recurrent gout flares when used at lower doses
- Decreases frequency and severity of attacks in familial Mediterranean fever (FMF)
- Targeted anti-inflammatory action with a well-understood mechanism
- Can be used in patients with contraindications to NSAIDs
- Helps prevent debilitating joint damage from recurrent inflammation
Common use
Colchicine is most commonly prescribed for the treatment of acute gout flares and for the prophylaxis of gout in patients experiencing frequent episodes. It is a cornerstone therapy for familial Mediterranean fever (FMF), used to prevent febrile episodes and associated complications such as amyloidosis. Off-label, it may be used in the management of other inflammatory conditions like pericarditis, Behçet’s disease, and pseudogout, though such use requires careful specialist evaluation.
Dosage and direction
For acute gout flare: An initial dose of 1.2 mg (two 0.6 mg tablets) at the first sign of a flare, followed by 0.6 mg one hour later. The total course for an acute attack should not exceed 1.8 mg over one hour. For gout prophylaxis: 0.6 mg once or twice daily, with dosage adjustments based on renal function, hepatic status, and concomitant medications. For FMF: Dosing is highly individualized, typically ranging from 1.2 mg to 2.4 mg daily, divided into one or two doses. Always take with a full glass of water, with or without food, but consistency is advised. Dosage must be strictly individualized by a healthcare provider.
Precautions
Use with extreme caution in patients with renal impairment; dosage reduction is mandatory. Hepatic impairment necessitates careful monitoring and potential dose adjustment. Avoid in patients with severe gastrointestinal, renal, or hepatic disorders. Elderly patients are at increased risk for adverse effects and toxicity. Patients should be advised to report any symptoms of muscle pain, weakness, numbness, or tingling promptly. Regular monitoring of complete blood count, renal function, and hepatic enzymes is recommended during prolonged therapy.
Contraindications
Contraindicated in patients with severe renal impairment (e.g., CrCl <30 mL/min) or severe hepatic impairment. Concomitant use with potent CYP3A4 inhibitors or P-glycoprotein inhibitors is contraindicated due to dramatically increased risk of life-threatening toxicity. Hypersensitivity to colchicine or any component of the formulation. Use is contraindicated in patients with pre-existing blood dyscrasias.
Possible side effect
Common side effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. These are often dose-related. Neuromuscular toxicity may manifest as myopathy, neuropathy, or rhabdomyolysis, particularly in at-risk patients. Hematological effects like leukopenia, granulocytopenia, thrombocytopenia, and aplastic anemia have been reported. Less frequently, alopecia and rash may occur. Serious side effects require immediate medical attention.
Drug interaction
Colchicine has significant and potentially fatal interactions. Concomitant use with strong CYP3A4 inhibitors (e.g., clarithromycin, ketoconazole, ritonavir) or P-glycoprotein inhibitors (e.g., cyclosporine) is contraindicated or requires drastic dose reduction. Moderate CYP3A4 inhibitors (e.g., verapamil, diltiazem) and certain statins (e.g., atorvastatin) increase toxicity risk. Use with other myelosuppressive drugs or nephrotoxic agents potentiates adverse effects. A comprehensive medication review is essential prior to initiation.
Missed dose
If a dose is missed for prophylaxis, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to make up for a missed one. For acute gout treatment, the dosing is a specific short-term regimen; if a dose is missed, contact a healthcare provider for guidance. Do not extend the treatment course for an acute flare.
Overdose
Colchicine overdose is extremely dangerous and can be fatal. Symptoms emerge in stages: initial gastrointestinal distress (nausea, vomiting, diarrhea) within 24 hours, followed by multi-organ failure (renal, hepatic, pulmonary), bone marrow suppression, and progressive neuromuscular toxicity. There is no specific antidote. Management is supportive and includes gastric lavage (if very recent), aggressive fluid and electrolyte management, and possibly granulocyte colony-stimulating factor for marrow suppression. Immediate hospitalization in an intensive care unit is mandatory.
Storage
Store at room temperature (20°C to 25°C or 68°F to 77°F), in a tight, light-resistant container. Keep away from excess moisture and heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Colchicine is a potent prescription medication with a narrow therapeutic index and serious risks. It must be used only under the direct supervision of a qualified healthcare professional who can assess individual patient factors, contraindications, and potential interactions. Never initiate, adjust, or discontinue colchicine without consulting your physician.
Reviews
“Colchicine has been profoundly effective in controlling my recurrent gout flares. The prophylactic low dose has drastically reduced my number of attacks. The key is strict adherence to the prescribed dosage to avoid side effects.” – J.D., verified patient.
“As a rheumatologist, colchicine remains a vital tool in our arsenal for acute gout and FMF. Its targeted mechanism is excellent, but it demands immense respect for its pharmacokinetics and interaction profile. Patient education on adherence and warning signs is non-negotiable.” – Dr. A. Sharma, MD.